Tris Pharma’s Wholly-Owned Subsidiary is Advancing the Development of Cebranopadol as it Prepares for New Drug Application (NDA) Submission Later This Year ...

Immunomic Therapeutics Inc. (ITI), a clinical-stage biotechnology company and a subsidiary of HLB, today announced that the first participant has been dosed in the Phase 1 clinical trial of ITI-9001, ...

A new generation of implantable devices could deliver drugs into the body and diagnose diseases more quickly. An ...

GLP-1 medications modulate a hormone that induces appetite. While users lose weight, there are also potential side effects including nausea, constipation, diarrhea, and vision issues in rare cases. Dr ...

You don't have to walk or drive far to see a child on an e-bike or scooter, but before you buy one, there are safety features ...

No scientific evidence supports the claim that turkey tail mushrooms shrink lipomas, the benign fatty tumors that commonly develop in dogs, according to Patton Veterinary Hospital.

Modulate's newest API detects AI-generated vocals and instrumentals directly from audio to provide a new layer of ...

Voice artificial intelligence company Modulate Inc. today launched a tool that flags AI-generated music straight from the audio. The product, an application programming interface called AI Music ...

Novel immune reprogramming oral macrocyclic peptides designed for precise modulation of complex biological networks involved in inflammatory, ...

Built on Modulate’s Ensemble Listening Model, Velma Enterprise API is the missing layer in real-world voice conversations. Experience it at Customer Contact Week Las Vegas. Boston, MA – June 3, 2026 – ...

Modulate is building the voice layer for the internet. There are dozens of public comparison datasets, universally accepted accuracy metrics, and no shortage of academic papers on ASR, so you might ...